Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study.

Daniel Q HuangLaura A WilsonCynthia BehlingMaral AmangurbanovaDavid E KleinerKris V KowdleySrinivasan DasarathyNorah A TerraultAnna Mae DiehlNaga ChalasaniBrent A Neuschwander-TetriArun J SanyalJames TonasciaStephen Caldwellnull null

Published in: Hepatology (Baltimore, Md.) (2024)

Using serial VCTE data from a multicenter study of participants with biopsy-proven metabolic dysfunction-associated steatotic liver disease, we demonstrate that T2DM and HbA1c are associated with LSM progression.

Keyphrases

glycemic control
type diabetes
cardiovascular disease
ultrasound guided
fine needle aspiration
oxidative stress
clinical trial
double blind
deep learning